An unauthenticated attacker can exploit this vulnerability by manipulating URL to achieve arbitrary file read access.This issue affects Valmet DNA Web Tools: C2022 and older.
Vendor
Valmet vulnerabilities
5 published CVES affecting Valmet, from public sources (CVE.org, NVD, CISA KEV, FIRST EPSS, OSV).
- Total
- 5
- Critical
- 0
- High
- 4
- Medium
- 1
- Low
- 0
- Unscored
- 0
- CISA KEV
- 0
Products
Latest Valmet CVEs
Newest publication first
-
HighCVSS 8.7 EPSS 0.56%
-
HighCVSS 8.9 EPSS 0.21%
Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is...
-
HighCVSS 7.0 EPSS 0.17%
Lack of protection against brute force attacks in Valmet DNA visualization in DNA Operate. The possibility to make an arbitrary number of login attempts without any rate limit gives an attacker an increased chance of guessing passwords and then performing switching operations.
-
MediumCVSS 5.2 EPSS 0.16%
Valmet DNA user passwords in plain text. This practice poses a security risk as attackers who gain access to local project data can read the passwords.
-
HighCVSS 8.8 EPSS 1.1%
A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions from Collection 2012 until Collection 2021.
Sources: CVE.org, NVD, CISA KEV, FIRST EPSS, OSV and public exploit-reference metadata. Product matching comes from the published CVE records. A proof-of-concept means public code exists; it is not evidence of exploitation.